evidence table

N Acetyl Cysteine Cognition Randomized Trial Evidence Table

Structured evidence table for N Acetyl Cysteine Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
N Acetyl Cysteine Cognition Randomized TrialA previous 28-day pilot trial of N-acetyl cysteine (NAC) vs placebo found NAC to be feasible and safe, with evidence of improvement on some measures of alcohol consumption.2Morley K (2025)N-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study).
N Acetyl Cysteine Cognition Randomized TrialIntroduction Current treatments for alcohol use disorders (AUD) have limited efficacy.2Morley K (2025)N-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study).
N Acetyl Cysteine Cognition Randomized TrialN-ACETYL-CYSTEINE (NAC) INTERVENTION AND MITOCHONDRIAL MECHANISMS IN- EARLY PSYCHOSIS PATIENTS4669. N-ACETYL-CYSTEINE (NAC) INTERVENTION AND MITOCHONDRIAL MECHANISMS IN- EARLY PSYCHOSIS PATIENTS (2025)669. N-ACETYL-CYSTEINE (NAC) INTERVENTION AND MITOCHONDRIAL MECHANISMS IN- EARLY PSYCHOSIS PATIENTS
topicN Acetyl Cysteine Cognition Randomized Trial
claimA previous 28-day pilot trial of N-acetyl cysteine (NAC) vs placebo found NAC to be feasible and safe, with evidence of improvement on some measures of alcohol consumption.
evidence level2
citationMorley K (2025)
sourceN-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study).
topicN Acetyl Cysteine Cognition Randomized Trial
claimIntroduction Current treatments for alcohol use disorders (AUD) have limited efficacy.
evidence level2
citationMorley K (2025)
sourceN-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study).
topicN Acetyl Cysteine Cognition Randomized Trial
claimN-ACETYL-CYSTEINE (NAC) INTERVENTION AND MITOCHONDRIAL MECHANISMS IN- EARLY PSYCHOSIS PATIENTS
evidence level4
citation669. N-ACETYL-CYSTEINE (NAC) INTERVENTION AND MITOCHONDRIAL MECHANISMS IN- EARLY PSYCHOSIS PATIENTS (2025)
source669. N-ACETYL-CYSTEINE (NAC) INTERVENTION AND MITOCHONDRIAL MECHANISMS IN- EARLY PSYCHOSIS PATIENTS

Learn next

Related evidence and supplement guides

GuideN Acetyl Cysteine Cognition Randomized Trial: What the Evidence SaysN Acetyl Cysteine Cognition Randomized Trial has 2 source documents in the current Migaku eviden...GuideN-acetylcysteine Cognition Randomized Trial: What the Evidence SaysN-acetylcysteine Cognition Randomized Trial has 2 source documents in the current Migaku evidenc...GuideN-acetylcysteine Oxidative Stress Randomized Trial: What the Evidence SaysN-acetylcysteine Oxidative Stress Randomized Trial has 2 source documents in the current Migaku...GuideSage Cognition Randomized Trial: What the Evidence SaysSage Cognition Randomized Trial has 2 source documents in the current Migaku evidence database....RankingBest Nootropics for Focus & Cognition: 2026 Clinical RankingsAn examination of cognitive enhancers designed to increase neurotransmitter activity, improve sy...AnswerDoes N Acetyl Cysteine Cognition Randomized Trial work?N Acetyl Cysteine Cognition Randomized Trial has evidence relevant to strength of evidence and w...AnswerIs N Acetyl Cysteine Cognition Randomized Trial safe?N Acetyl Cysteine Cognition Randomized Trial has evidence relevant to safety, limits, and clinic...AnswerWhat does the evidence say about N Acetyl Cysteine Cognition Randomized Trial?N Acetyl Cysteine Cognition Randomized Trial has evidence relevant to benefits, uncertainty, and...

Source documents

  1. N-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study).
  2. 669. N-ACETYL-CYSTEINE (NAC) INTERVENTION AND MITOCHONDRIAL MECHANISMS IN- EARLY PSYCHOSIS PATIENTS